DK1293210T3 - Midler og fremgangsmåde til hormonal prævention - Google Patents

Midler og fremgangsmåde til hormonal prævention

Info

Publication number
DK1293210T3
DK1293210T3 DK01201945T DK01201945T DK1293210T3 DK 1293210 T3 DK1293210 T3 DK 1293210T3 DK 01201945 T DK01201945 T DK 01201945T DK 01201945 T DK01201945 T DK 01201945T DK 1293210 T3 DK1293210 T3 DK 1293210T3
Authority
DK
Denmark
Prior art keywords
hormone units
estrogen
daily
phase
units
Prior art date
Application number
DK01201945T
Other languages
Danish (da)
English (en)
Inventor
Beek Agatha Antonia Magdal Van
Bennink Herman Jan Ti Coelingh
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of DK1293210T3 publication Critical patent/DK1293210T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
DK01201945T 2001-05-23 2001-05-23 Midler og fremgangsmåde til hormonal prævention DK1293210T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01201945A EP1293210B1 (en) 2001-05-23 2001-05-23 Means and method for hormonal contraception

Publications (1)

Publication Number Publication Date
DK1293210T3 true DK1293210T3 (da) 2004-03-15

Family

ID=8180360

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01201945T DK1293210T3 (da) 2001-05-23 2001-05-23 Midler og fremgangsmåde til hormonal prævention

Country Status (10)

Country Link
US (1) US20040242550A1 (pt)
EP (1) EP1293210B1 (pt)
AT (1) ATE254465T1 (pt)
CA (1) CA2448280A1 (pt)
DE (1) DE60101276T2 (pt)
DK (1) DK1293210T3 (pt)
ES (1) ES2208518T3 (pt)
PT (1) PT1293210E (pt)
TR (1) TR200400183T4 (pt)
WO (1) WO2002094281A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100528167C (zh) 2002-10-23 2009-08-19 潘塔希生物科学股份有限公司 用于治疗癌症的包含雌四醇衍生物的药物组合物
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
ES2314156T3 (es) * 2003-03-28 2009-03-16 Pantarhei Bioscience B.V. Metodo anticonceptivo para mamiferos hembra y kit para usar en dicho metodo.
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
CN101198335A (zh) * 2004-09-27 2008-06-11 潘塔希生物科学股份有限公司 雌性避孕的方法以及该用途的药盒
DE102005056527A1 (de) * 2005-11-25 2007-07-12 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
US20080021003A1 (en) * 2006-06-13 2008-01-24 Vladimir Hanes Extended step-down estrogen regimen
UA123098C2 (uk) * 2015-06-18 2021-02-17 Естетра Спрл Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент
PE20231714A1 (es) 2015-06-18 2023-10-23 Estetra Sprl Unidad de dosificacion orodispersable que contiene un componente estetrol
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN109820859A (zh) * 2019-04-09 2019-05-31 上海市计划生育科学研究所 醋酸诺美孕酮在制备预防或治疗呕吐或改善恶病质的药物中的应用
WO2023135506A1 (en) * 2022-01-13 2023-07-20 Arena Pharmaceuticals, Inc. Etrasimod for use in treating s1p1 receptor-associated disorders in combination with hormone treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
WO2002094281A1 (en) 2002-11-28
TR200400183T4 (tr) 2004-02-23
ES2208518T3 (es) 2004-06-16
DE60101276T2 (de) 2004-04-22
CA2448280A1 (en) 2002-11-28
EP1293210A1 (en) 2003-03-19
EP1293210B1 (en) 2003-11-19
ATE254465T1 (de) 2003-12-15
PT1293210E (pt) 2004-04-30
US20040242550A1 (en) 2004-12-02
DE60101276D1 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
DK1293210T3 (da) Midler og fremgangsmåde til hormonal prævention
Yuzpe et al. Post coital contraception--A pilot study
BG111090A (bg) Контрацептивен процес и форми на приложение за същия
NO982902L (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
DE59808545D1 (de) Mittel zur hormonalen kontrazeption
DK0491438T3 (da) Svangerskabsforebyggende behandling
RS20060348A (en) Extended use combination comprising estrogens and progestins
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE11371T1 (de) Multistufen-kombinationssequentialpraeparate fuer die orale kontrazeption und verfahren zur kontrazeption.
WO2006042021B1 (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
ATE410171T1 (de) Graduierte östrogen-kontrazeptiva
HUP9904508A2 (hu) Egy ösztrogén vegyületet és egy progesztatív vegyületet tartalmazó hormonkészítmény
Bygdeman et al. Medical termination of early pregnancy: the Swedish experience
BR0206367A (pt) Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade
NO974255L (no) Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
WO2000078298A3 (en) Programming ovulation by administering estrogen such as estradiol
AR032371A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
BR0010070A (pt) Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio
Wood Hormonal contraception: current perspectives. Part I. An analysis of available agents
JPS5248655A (en) Preparation of 19-nor-3-hydroxy-1,3,5(10)-triene steroids
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases